1. Introduction {#sec1-nutrients-10-00429}
===============

Exclusively breastfed infants who are not supplemented with vitamin D are at increased risk for insufficient vitamin D and associated short- and long-term bone health consequences \[[@B1-nutrients-10-00429],[@B2-nutrients-10-00429],[@B3-nutrients-10-00429]\]. Additionally, low vitamin D status has been associated with increased maternofetal-related morbidity, including preeclampsia, gestational diabetes, delivery of small for gestational age infants, and juvenile onset type 1 diabetes \[[@B4-nutrients-10-00429],[@B5-nutrients-10-00429],[@B6-nutrients-10-00429]\]. The vitamin D content of breast milk is very much dependent on maternal vitamin D status \[[@B7-nutrients-10-00429],[@B8-nutrients-10-00429],[@B9-nutrients-10-00429]\]. Health Canada \[[@B10-nutrients-10-00429]\] and the Institute of Medicine (IOM) \[[@B11-nutrients-10-00429]\] have recommended 600 International Units (IU)/day of vitamin D for pregnant and breastfeeding women and 400 IU/day for infants, with the goal of achieving sufficient vitamin D status in the infant. However, studies in pregnant and breastfeeding mothers have shown a large proportion of these women having suboptimal vitamin D status despite reporting intakes that meet these recommendations \[[@B12-nutrients-10-00429],[@B13-nutrients-10-00429],[@B14-nutrients-10-00429],[@B15-nutrients-10-00429],[@B16-nutrients-10-00429]\].

Optimal vitamin D intake, as well as optimal 25(OH)D concentration, for breastfeeding mothers and their infants is not fully established \[[@B11-nutrients-10-00429],[@B17-nutrients-10-00429],[@B18-nutrients-10-00429]\]. The IOM has recommended a 25(OH)D cut-point of \>50 nmol/L to define vitamin D sufficiency \[[@B11-nutrients-10-00429]\], but some studies suggest that an optimal level for bone health might be somewhat higher \[[@B19-nutrients-10-00429],[@B20-nutrients-10-00429],[@B21-nutrients-10-00429],[@B22-nutrients-10-00429]\]. Considering these studies, Osteoporosis Canada \[[@B17-nutrients-10-00429]\] and the Endocrine Society \[[@B18-nutrients-10-00429]\] have recommended a serum concentration of \>75 nmol/L as the target for optimal bone health.

Clinical trials of vitamin D supplementation during breastfeeding have shown that an intake of 400 IU/day by breastfeeding mothers was not enough to achieve a vitamin D status \>75 nmol/L in their infants \[[@B23-nutrients-10-00429],[@B24-nutrients-10-00429],[@B25-nutrients-10-00429]\]. There is data to suggest maternal daily doses of 4000--6400 IU/day are needed to improve and maintain 25(OH)D concentration ≥75 nmol/L in exclusively breastfed infants who are not taking any vitamin D supplements \[[@B23-nutrients-10-00429],[@B24-nutrients-10-00429],[@B25-nutrients-10-00429]\]. Consistent with this, a study examining different levels of vitamin D supplementation on vitamin D status in healthy breastfed infants showed supplementing infants with 400 IU/day achieved a 25(OH)D concentration ≥75 nmol/L in only 55% of infants \[[@B26-nutrients-10-00429]\]. Intakes of up to 1000 IU/day by infants and 4000--10,000 IU/day by adults, including breastfeeding mothers, is recognized as intakes without negative health consequences (UL, Tolerable Upper Intake Level) by the IOM \[[@B11-nutrients-10-00429]\].

Although the literature on vitamin D in breastfeeding mothers and infants is growing, most of the recently published studies of breastfeeding mothers have focused on either mothers or infants as a method of improving/maintaining vitamin D status in infants \[[@B23-nutrients-10-00429],[@B24-nutrients-10-00429],[@B25-nutrients-10-00429],[@B26-nutrients-10-00429]\]. As current recommendations are aimed at both mother and infant, it is logical and important to consider both.

We examined the association between maternal vitamin D intake during breastfeeding with their infants' vitamin D status in infants who did or did not receive vitamin D supplements to determine whether infant supplementation was sufficient.

2. Materials and Methods {#sec2-nutrients-10-00429}
========================

This study is a secondary analysis of the APrON study (Alberta Pregnancy Outcomes and Nutrition; <http://www.apronstudy.ca/>), a prospective cohort of pregnant women and their children residing in Calgary and Edmonton (Alberta, Canada). APrON recruited a total of 2140 women between March 2009 and July 2012; 500 blood samples were available from their infants at three months of age. All participants provided informed consent to permit use of their data and blood samples for various research questions. The University of Calgary Health Research Ethics Board and the University of Alberta Health Research Ethics Biomedical Panel approved the project. Full details of the APrON study are described elsewhere \[[@B27-nutrients-10-00429]\].

2.1. Dietary Data {#sec2dot1-nutrients-10-00429}
-----------------

At each pregnancy visit and at 3 months postpartum, women were asked to describe in detail the quantity and type of foods and beverages consumed in the previous 24-h period (midnight to midnight). In addition, a Supplemental Intake Questionnaire (SIQ) \[[@B28-nutrients-10-00429]\] was developed for the APrON study that was based on questionnaires used in previous studies \[[@B28-nutrients-10-00429]\], and was adapted for use with pregnant women. This questionnaire was designed to capture the daily estimated intake of natural health products during each trimester of pregnancy \[[@B28-nutrients-10-00429]\]. Furthermore, mothers answered questions at 3, 6, 12, 24, and 36 months postpartum about infant feeding practices, including whether they were providing a daily vitamin D supplement to their infant \[[@B27-nutrients-10-00429]\].

2.2. Biological Samples {#sec2dot2-nutrients-10-00429}
-----------------------

Maternal blood sample was collected at each clinic visit by a certified phlebotomist. In addition, an infant blood sample was collected at 3 months of age by a certified phlebotomist. Plasma was separated immediately, aliquoted, and stored in micro-centrifuge tubes at −80 °C for future analysis \[[@B27-nutrients-10-00429]\]. All frozen collected plasma was assayed alongside plasma quality control samples and standard reference materials using a clinically validated liquid chromatography tandem mass spectrometry (LC-MS/MS) assay at the laboratory of Doctor's Data Inc. (St. Charles, IL, USA) \[[@B29-nutrients-10-00429]\], which measured 25(OH)D~2~, 25(OH)D~3~, and 3-epi-25(OH)D~3~ and demonstrated an intra-assay coefficient of variability of 4.6% at 28.3 nmol/L, 3.3% at 83.9 nmol/L, and 3.9% at 5.8 nmol/L for 25(OH)D~2~, 25(OH)D~3~, and 3-epi-25(OH)D~3~, respectively. Information on processing blood samples and integrity of plasma samples has been previously reported \[[@B29-nutrients-10-00429]\]. The concentrations of 25(OH)D~2~, 25(OH)D~3~, and 3-epi-25(OH)D~3~ in plasma were determined using LC-MS/MS (the National Institute of Standard and Technology (NIST) standards and Vitamin D External Quality Assessment Scheme (DEQAS) procedures were followed), as previously described \[[@B29-nutrients-10-00429]\].

2.3. Statistical Analysis {#sec2dot3-nutrients-10-00429}
-------------------------

Results are presented for plasma 25(OH)D~2~, 25(OH)D~3~, and 3-epi-25(OH)D~3~ as means and standard deviations (SD) and medians and interquartile ranges (IQR). The prevalence rates of vitamin D deficiency and insufficiency in infants were estimated as percentages. Plasma concentrations of 25(OH)D at \<25 nmol/L, \<50 nmol/L, and \<75 nmol/L \[[@B11-nutrients-10-00429],[@B17-nutrients-10-00429],[@B18-nutrients-10-00429]\] were used to reflect several laboratory definitions of vitamin D status currently used. The correlation between maternal vitamin D intake and infants' 25(OH)D concentration was determined using the Pearson correlation coefficient test. A multiple linear regression analysis was used to examine the association between infants' plasma 25(OH)D (D~2~ + D~3~) concentration and mothers' estimated dietary vitamin D intake (supplements and diet) adjusted for the potential covariates of birthweight, second trimester (mid-pregnancy) maternal plasma 25(OH)D (D~2~ + D~3~), season (summer from 1 May--31 October and winter from 1 November--30 April), race (Caucasian vs. non-Caucasian) and infants' vitamin D supplement status (yes or no, as the actual dose was not measured). All analyses were conducted using SPSS (V22.0, IBM Corporation, Armonk, NY, USA). *p*-values \< 0.05 were considered statistically significant.

3. Results {#sec3-nutrients-10-00429}
==========

We analyzed 224 blood samples of infants whose mothers' vitamin D status (at second trimester) and intake was available ([Table 1](#nutrients-10-00429-t001){ref-type="table"}). Fifty-five percent of infants were male, with a mean birthweight of 3377.8 ± 478.3 g. Data on infant feeding was accessible for 209 infants for whom vitamin D status was available; 72% were exclusively breastfed, 12% were formula fed, and 16% were mix fed (receiving both breast milk and formula). Ninety percent of exclusively breastfed infants were provided a vitamin D supplement. Overall, 80% of mothers in the APrON study provided vitamin D supplementation to their infants \[[@B30-nutrients-10-00429]\].

25(OH)D~2~, 25(OH)D~3~, 3-epi-25(OH)D~3~ were identified in 224 plasma samples at three months of age, and 3-epi-25(OH)D~3~ contributed 15% of the total vitamin D status ([Table 2](#nutrients-10-00429-t002){ref-type="table"}). Infants' median (25(OH)D~2~ + 25(OH)D~3~) was 96.0 (IQR 77.6--116.2). Twenty-three percent of infants had 25(OH)D \< 75 nmol/L, and 8% had 25(OH)D \< 50 nmol/L. These percentages were slightly higher in exclusively breastfed infants (25% \< 75 nmol/L and 10% \< 50 nmol/L).

Maternal mean age was 31.3 ± 4.5, and participants were primarily Caucasian (82%) with a pre-pregnancy body mass index (BMI) of 24.2 ± 4.7. Fifty-eight percent of participants were primiparous, 60% had a trade or university degree, and 60% had income higher than \$100,000 CDN. The median estimated maternal vitamin D intake from diet, supplements, and both during the postpartum period were 184, 400, and 665 IU/day, respectively. Twenty-three percent of lactating mothers were not meeting the Estimated Average Requirements (EAR) for vitamin D (400 IU/day). There was a positive correlation between maternal daily dietary vitamin D intake and infants' plasma 25(OH)D concentration in infants exclusively breastfed at three months of age (*r* = 0.18, *p* = 0.006) ([Figure 1](#nutrients-10-00429-f001){ref-type="fig"}). In addition, there was a positive correlation between maternal daily dietary vitamin D intake and infants' plasma 3-epi-25(OH)D~3~ concentration in infants exclusively breastfed at three months of age (*r* = 0.27, *p* = 0.01). However, there was no relationship between infants' plasma 25(OH)D at three months of age and second trimester maternal plasma 25(OH)D (*r* = 0.07, *p* = 0.32).

There was a significant association between infants' plasma 25(OH)D and maternal reported vitamin D intake at three months postpartum in an adjusted linear regression model (β = 0.008, 95% CI 0.002, 0.13). Infants' plasma 25(OH)D was also associated with infants' vitamin D intake (β = 16.31, 95% CI 2.69, 29.93) and birth weight (β = −0.013, 95% CI −0.023, −0.002). Season of sampling, race, and second trimester maternal plasma 25(OH)D were not significantly associated with infants' plasma 25(OH)D concentration ([Table 3](#nutrients-10-00429-t003){ref-type="table"}). With each 100 IU increase in vitamin D intake by mothers, the infants' total plasma 25(OH)D increased by 0.9 nmol/L when controlling for race, season, second trimester maternal plasma 25(OH)D, birth weight, and whether the infant received a daily vitamin D supplement.

4. Discussion {#sec4-nutrients-10-00429}
=============

We found that one-fourth of exclusively breastfed infants had 25(OH)D concentration \<75 nmol/L despite the fact that 90% of mothers reported providing a daily vitamin D supplement. Although we did not have data on the dose of vitamin D supplement in infants, the commercial Canadian vitamin D drop for infants contain 400 IU/drop \[[@B10-nutrients-10-00429]\], suggesting that this alone is not sufficient to ensure optimal status. Consistent with this, we showed that there is a significant relationship between maternal postpartum vitamin D intake from both diet and supplements and the vitamin D status of infants who were supplemented at three months of age. Although the IOM \[[@B11-nutrients-10-00429]\] current recommendation for insufficient vitamin D status is 25(OH)D \<50 nmol/L, this is not considered optimal status by other organizations \[[@B17-nutrients-10-00429],[@B18-nutrients-10-00429]\]; we therefore reported our findings based on 25(OH)D \<75 nmol/L. Nevertheless, we found that 10% of exclusively breasted infants in our samples had concentrations of 25(OH)D \<50 nmol/L despite receiving a daily vitamin D supplement.

Previous clinical trials have reported improved infant vitamin D status with either increasing maternal vitamin D intake \[[@B23-nutrients-10-00429],[@B24-nutrients-10-00429],[@B25-nutrients-10-00429]\] or infants' vitamin D supplements \[[@B27-nutrients-10-00429]\]; however, to our knowledge, no study has reported the impact of both maternal vitamin D intake and infants receiving the current daily vitamin D recommended supplement on infant's vitamin D status. Although previous studies have shown that breastfed infants who are not provided vitamin D supplements are reliant on their mothers' vitamin D intake \[[@B23-nutrients-10-00429],[@B24-nutrients-10-00429],[@B25-nutrients-10-00429]\], our study showed that breastfed infants' vitamin D status depends on their mother's vitamin D intake even in those infants who are supplemented by vitamin D. Our analysis of breastfeeding mothers in the APrON study has shown that 23% were not meeting the EAR of 400 IU/day, which would negatively impact infants' vitamin D status and health. These results suggest that, to ensure infant optimal vitamin D status, not only do infants require a supplement, but women also need to meet current vitamin D intake during breastfeeding, which for the majority of women would require a supplement. This study also provides evidence that the current IOM recommendation for breastfeeding mothers is not sufficient to ensure adequate vitamin D status of infants.

Our results contribute to the growing literature on vitamin D status and intake in breastfeeding mothers and infants worldwide \[[@B23-nutrients-10-00429],[@B24-nutrients-10-00429],[@B25-nutrients-10-00429],[@B26-nutrients-10-00429],[@B31-nutrients-10-00429],[@B32-nutrients-10-00429],[@B33-nutrients-10-00429],[@B34-nutrients-10-00429],[@B35-nutrients-10-00429]\]. Several recent studies have shown low vitamin D status is common in exclusively breastfed infants and their mothers and is associated with sun exposure and vitamin D supplementation \[[@B31-nutrients-10-00429],[@B32-nutrients-10-00429],[@B33-nutrients-10-00429],[@B34-nutrients-10-00429],[@B35-nutrients-10-00429]\]. A few RCTs have shown that maternal supplementation with vitamin D during the breastfeeding period is an effective way to increase infants' vitamin D status in those not receiving supplementation. These studies have used different doses, from 2000 IU/day \[[@B20-nutrients-10-00429]\] to 6400 IU/day \[[@B25-nutrients-10-00429]\], or high doses of vitamin D (60,000 daily for 10 days), for better compliance \[[@B24-nutrients-10-00429]\]. Vitamin D status of exclusively breastfed infants depends on sunlight exposure, vitamin D store at birth, and secretion in breast milk \[[@B31-nutrients-10-00429],[@B32-nutrients-10-00429],[@B33-nutrients-10-00429],[@B34-nutrients-10-00429],[@B35-nutrients-10-00429]\]. A study of breastfeeding mothers from different geographic areas (latitude range 3° N to 54° N) has shown that the vitamin D content of breast milk is well below the IOM recommended dose of 400 IU/day for 0--6-month-old infants \[[@B33-nutrients-10-00429]\]. A review of 22 case reports (166 infants) with nutritional rickets during 1986--2003 from the United States showed that 96% of children were breastfed and only 5% of them reported receiving a vitamin D supplementation \[[@B36-nutrients-10-00429]\].

Vitamin D supplementation of all breastfed infants has been recommended by the IOM \[[@B11-nutrients-10-00429]\] and other organizations \[[@B10-nutrients-10-00429],[@B37-nutrients-10-00429],[@B38-nutrients-10-00429]\]. In our study, compliance rate of vitamin D supplementation in breastfeeding infants was high (90%); however, other studies have shown low compliance rates of vitamin D supplementation in breastfeeding infants from 2--19% \[[@B39-nutrients-10-00429],[@B40-nutrients-10-00429],[@B41-nutrients-10-00429],[@B42-nutrients-10-00429]\]. A longitudinal study of effectiveness of supplementation of vitamin D in Japanese breastfed infants showed that adequate vitamin D intake is effective in preventing vitamin D deficiency in infants when their mothers actively participated in the study \[[@B31-nutrients-10-00429]\]. However, another US study was not able to make a valid assessment of the effect of infants' supplementation on their status due to the low number of infants supplemented with vitamin D \[[@B35-nutrients-10-00429]\].

Our study had a lower rate of vitamin D insufficiency in infants and their mothers compared to other studies \[[@B13-nutrients-10-00429],[@B14-nutrients-10-00429],[@B15-nutrients-10-00429],[@B16-nutrients-10-00429],[@B31-nutrients-10-00429],[@B32-nutrients-10-00429],[@B33-nutrients-10-00429],[@B34-nutrients-10-00429],[@B35-nutrients-10-00429]\], which is due to the high compliance rate of taking vitamin D supplements by both mothers and their infants in the APrON cohort. In addition, a higher rate of mothers (72%) exclusively breasted their infants in the first 3--6 months of life, which is higher than the national average. In Canada, 89% of mothers breastfed their infant in 2011--2012, and 26% were breastfeeding exclusively for six months \[[@B43-nutrients-10-00429]\]. The high compliance rate of supplementation as well as breastfeeding in our study is likely due to the cohort being well educated and of high socio-economic status, which could influence the generalizability of study findings to the entire population. Another limitation of our study is the lack of information on sun exposure, skin color, and clothing coverage of participants, as well as the quantity of vitamin D supplementation in infants. However, due to the long winters in Alberta and Calgary's high latitude (51° N), the effect of sun exposure and dermal synthesis may be less critical. In addition, given that vitamin D from food in Canada makes such a small overall contribution to vitamin D dietary intake, the major factor that could affect vitamin D status is supplement intake.

We also demonstrated the presence of 3-epi-25(OH)D~3~ in all infants' plasma samples. Overall, the epimer contributed 15% of total vitamin D status, and it was very high in some infants (range 0.8--55.64). This finding is consistent with previous studies showing that epimer can alter vitamin D status estimation of pregnant women at the time of delivery and in their cord blood \[[@B29-nutrients-10-00429],[@B44-nutrients-10-00429]\]. Previous studies have shown factors such as age, season, and vitamin D supplementation can affect 3-epi-25(OH)D~3~ \[[@B44-nutrients-10-00429]\]. In our study, there was a significant positive correlation between infants' plasma 3-epi-25(OH)D~3~ and maternal vitamin D intake. In addition, 90% of infants were given supplements. This again suggests that vitamin D supplements could be a source for 3-epi-25(OH)D~3~, as shown in previous studies \[[@B29-nutrients-10-00429],[@B44-nutrients-10-00429]\].

5. Conclusions {#sec5-nutrients-10-00429}
==============

Our findings suggest that to ensure infant optimal vitamin D status, not only do infants require a supplement, but women also need to take supplemental intakes (\>400 IU/day) of vitamin D during breastfeeding.
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nutrients-10-00429-t001_Table 1

###### 

Characteristics of infants.

  --------------------------------------------------------------------------------------------------------------
  Characteristics                                All Infants\         Exclusively Breastfed Infant (*n* = 152)
                                                 (*n* = 224)          
  ---------------------------------------------- -------------------- ------------------------------------------
  Male, *n* (%)                                  122 (54.5)           83 (54.6)

  Female, *n* (%) ^1^                            102 (44.6)           69 (45.4)

  Ethnicity (*n* = 224)                          204 (91.1)           144 (94.7)

  Caucasian, *n* (%)                             204 (91.1)           144 (94.7)

  Other, *n* (%)                                 20 (8.9)             8 (5.3)

  Vitamin D intake ^2^, *n* (%)                  172 (76)             139 (91)

  25(OH)D (D~2~ + D~3~) (Median (25th--75th))\   96.0 (77.6--116.2)   94.5 (76.9--115.1)
  nmol/L                                                              

  3-epi-25(OH)D~3~\                              15.6 ± 11.2          15.7 ± 10.9
  nmol/L                                                              

  Birth Weight (g)\                              3377.8 ± 478.3\      3444.4 ± 444.9\
  (Mean ± SD)                                    (*n* = 212)          (*n* = 142)

  Birth Length (cm)\                             50.9 ± 2.7\          51.2 ± 2.5\
  (Mean ± SD)                                    (*n* = 209)          (*n* = 140)

  Birth Head Circumference (cm)\                 34.5 ± 1.6\          34.6 ± 1.5\
  (Mean ± SD)                                    (*n* = 211)          (*n* = 142)
  --------------------------------------------------------------------------------------------------------------

^1^ Gender is missing for two infants. ^2^ Infants' vitamin D dose was not collected. SD: standard deviations.

nutrients-10-00429-t002_Table 2

###### 

Vitamin D status (nmol/L) of infants and mothers.

  ------------------------- --------------- --------------------------- ----------------------
  **Infants (*n* = 224)**   **Mean ± SD**   **Median (25th to 75th)**   **Range (Min--Max)**
  25(OH)D~3~                96.1 ± 33.0     95.5 (77.6--116.2)          197.4 (12.5--209.9)
  25(OH)D~2~                0.1 ± 0.5       0                           3.5 (0--3.5)
  25(OH)D (D~2~ + D~3~)     97.1 ± 33.9     96.0 (77.6--116.2)          197.43 (12.5--209.9)
  3-epi-25(OH)D~3~          15.6 ± 11.2     11.66 (7.7--21.2)           54.8 (0.8--55.6)
  **Mothers (*n* = 224)**                                               
  25(OH)D~3~                73.8 ± 28.6     75.5 (49.1--95.1)           145.3 (17.8--163.1)
  25(OH)D~2~                2.2 ± 1.8       1.8 (0--3.4)                14.9 (0--14.9)
  25(OH)D (D~2~ + D~3~)     76.0 ± 29.6     77.7 (49.1--95.1)           148.2 (17.8--166.0)
  3-epi-25(OH)D~3~          4.3 ± 2.1       4.3 (2.5--5.7)              11.5 (0.4--11.9)
  ------------------------- --------------- --------------------------- ----------------------

nutrients-10-00429-t003_Table 3

###### 

Multiple regression model for 25(OH)D of infants.

  Item                        25(OH)D ^a^, β (95% CI)   *p*
  --------------------------- ------------------------- -------
  Maternal vitamin D intake   0.008 (0.002, 0.13)       0.010
  Infants' vitamin D intake   16.31 (2.69, 29.93)       0.019
  Season ^a^                  −6.49 (−16.86, 3.88)      0.219
  Birth weight                −0.013 (−0.23, −0.002)    0.024
  Maternal 25(OH)D ^b^        0.50 (−0.12, 0.22)        0.564
  Race ^c^                    −2.93 (−20.01, 14.14)     0.735

^a^ Summer (3 May--31 October) versus winter (1 November--30 April). ^b^ nmol/L. ^c^ Caucasian versus non-Caucasian. CI: confidence interval.
